Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda Makes $1 Billion Move For Amgen Development Rights

Feb 05 2008

• By PharmAsia News

Related Content

Amgen Partners With Daiichi-Sankyo For Denosumab In Japan

Jul 13 2007

Takeda To Help Develop Lundbeck's First-In-Class Mood Disorder Candidates In Japan, U.S.

Sep 07 2007

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window